DBV Jumps 41% To $9.96 After Update On Viaskin Peanut Filing
February 13, 2019 at 17:49 PM EST
Shares of DBV Technologies jumped after the company said that its planned resubmission of the Biologics License Application to the FDA for Viaskin Peanut is anticipated in the third quarter of 2019.